CSIMarket
 
Intercure Ltd   (NASDAQ: INCR)
 
Price: $5.2900 $0.13 2.519%
Day's High: $5.320000171661377 Week Perf: -1.86 %
Day's Low: $ 5.12 30 Day Perf: 471.27 %
Volume (M): 2,871 52 Wk High: $ 6.10
Volume (M$): $ 0 52 Wk Avg: $1.32
Open: $5.12 52 Wk Low: $0.68



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees 450
 Revenues (TTM) (Millions $) 270
 Net Income (TTM) (Millions $) -37
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 4

Business Description


Intercure Ltd is a pharmaceutical company that is primarily focused on developing innovative treatments for various medical conditions. Founded in 2008 in Israel, the company has since expanded its presence to other parts of the world. It is known for its expertise in developing cutting-edge treatments that are designed to meet the needs of patients who are suffering from various diseases.

One of the key strengths of Intercure Ltd is its research and development capabilities. The company has a team of highly skilled scientists and researchers who are dedicated to discovering new and innovative treatments for different medical conditions. They work closely with healthcare professionals and other stakeholders in the pharmaceutical industry to ensure that the treatments being developed are safe, effective, and affordable.

Intercure Ltd's product portfolio includes a range of medications that are used to treat cardiovascular diseases, neurological conditions, and other medical conditions. One of the company's most notable products is the RESPeRATE device, which is a non-drug treatment for hypertension. The device works by slowing down the breathing rate, which helps to reduce blood pressure.

In addition to its focus on research and development, Intercure Ltd has also established partnerships with other pharmaceutical companies and healthcare providers. These partnerships have helped the company to expand its reach and develop new treatments that are tailored to the needs of patients.

Overall, Intercure Ltd is a pharmaceutical company that is committed to improving the health and well-being of people around the world. With its focus on research and development, partnerships, and dedication to producing safe and effective treatments, the company is well-positioned to continue its growth and success in the coming years.


   Company Address: 85 Medinat ha-Yehudim Street Herzliya 4676670
   Company Phone Number: 77 460 5012   Stock Exchange / Ticker: NASDAQ INCR


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CPMD   -16.67%    
CVSI   -10%    
ETST      0% 
IGC   -5.24%    
INM   -5.8%    
LIFD      0% 
• View Complete Report
   



Business Update

InterCure and Cookies Forge a New Path in German Cannabis A Strategic Alliance for Growth,

Published Wed, Aug 28 2024 1:47 PM UTC

In a significant move set to enhance its market presence, InterCure Ltd. (NASDAQ: INCR) (TASE: INCR), a leading vertically integrated medical cannabis company known for its innovative strategies, announced the expansion of its strategic partnership with the globally acclaimed cannabis brand, Cookies. This collaboration aims to cultivate, manufacture, import, and distribute C...

Product Service News

InterCure Expanding its Global Presence as Germany Embraces Cannabis Reform

Published Fri, Mar 22 2024 3:58 PM UTC

The passing of the CannG Cannabis Act in Germany marks a significant milestone in the global cannabis industry. InterCure, a leading medical cannabis company based in Israel, is poised to capitalize on this development by expanding its operations and product offerings in Germany. This article explores the implications of the new legislation on InterCure s business strategy a...

Management Announcement

InterCure Overcomes Challenges, Provides Update on Nir Oz Facility Amidst Security Situation in Israel

Published Tue, Feb 13 2024 9:47 PM UTC


InterCure Provides an Update Regarding Nir Oz Facility
InterCure, the leading medical cannabis company in Israel and outside of North America, has released an update regarding the status of its facility in Kibbutz Nir Oz, also known as the Southern Israel Site. This update comes in response to the security situation in Israel and its impact on the company and its em...

Merger and Acquisition

InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain, Strengthening its Hold in the Medical Cannabis Market.

Published Wed, Jan 31 2024 2:28 PM UTC

InterCure Ltd, a leading medical cannabis company in Israel and beyond, has recently made a significant move to further establish its dominance in the market. The company announced today that it has entered into a share purchase agreement with the shareholders of Leon Pharm Ltd to acquire the renowned pharmacy chain. Leon Pharm is recognized for its specialization in dispens...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.22
Working Capital Ratio 1.37
Leverage Ratio (MRQ) 0.74
Total Debt to Equity 0.15
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 0 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash -
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 600,444
Net Income per Employee (TTM) -81,742
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.41

Profitability Ratios Current
Gross Margin (MRQ) 12.28 %
Operating Margin (MRQ) -10.08 %
Net Margin (MRQ) -13.61 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Intercure Ltd's Segments
Cannabis segment    100 % of total Revenue
Reportable segments    100 % of total Revenue
One customer    10.36 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.